Colombian consensus recommendations for diagnosis, management and treatment of the infection by SARS-COV-2/ COVID-19 in health care facilities - Recommendations from expert´s group based and informed on evidence

La Asociación Colombiana de Infectología (ACIN) y el Instituto de Evaluación de Nuevas Tecnologías de la Salud (IETS) conformó un grupo de trabajo para desarrollar recomendaciones informadas y basadas en evidencia, por consenso de expertos para la atención, diagnóstico y manejo de casos de Covid 19. Estas guías son dirigidas al personal de salud y buscar dar recomendaciones en los ámbitos de la atención en salud de los casos de Covid-19, en el contexto nacional de Colombia

In Vitro Bioactivity of Methanolic Extracts from Amphipterygium adstringens (Schltdl.) Schiede ex Standl., Chenopodium ambrosioides L., Cirsium mexicanum DC., Eryngium carlinae F. Delaroche, and Pithecellobium dulce (Roxb.) Benth. Used in Traditional Medicine in Mexico

Seven out of eight methanolic extracts from five plants native to Mexico were inactive against ten bacterial strains of clinical interest. The fruit extract of Chenopodium ambrosioides inhibited the bacteria Enterococcus faecalis (MIC = 4375 μg/ml), Escherichia coli (MIC = 1094 μg/ml), and Salmonella typhimurium (MIC = 137 μg/ml). The fruit extract of C. ambrosioides was with CC50 = 45 μg/ml most cytotoxic against the cell-line Caco-2, followed by the leaf extract from Pithecellobium dulce (CC50 = 126 μg/ml); interestingly, leaves of C. ambrosioides (CC50 = 563 μg/ml) and bark of P. dulce (CC50 = 347 μg/ml) extracts were much less cytotoxic. We describe for the first time the cytotoxic effect from extracts of the aerial parts and the flowers of Cirsium mexicanum (CC50 = 323 μg/ml and CC50 = 250 μg/ml, resp.). Phytochemical analysis demonstrated for both extracts high tannin and saponin and low flavonoid content, while terpenoids were found in the flowers. For the first time we report a cytotoxicological study on an extract of Eryngium carlinae (CC50 = 356 μg/ml) and likewise the bark extract from Amphipterygium adstringens (CC50 = 342 μg/ml). In conclusion the fruit extract of C. ambrosioides is a potential candidate for further biological studies

Evaluation of Somaclonal and Ethyl Methane Sulfonate-Induced Genetic Variation of Mexican Oregano (<i>Lippia graveolens</i> H.B.K.)

Lippia graveolens, commonly known as Mexican oregano, is an aromatic plant of great industrial, nutritional, and medicinal value, principally for its essential oils. Regeneration via axillary buds was established in MS medium supplemented with 6-benzyladenine (BA) (0.5 mgL&#8722;1) as a growth regulator. Three genotypes and three stages of cultivation were considered in the study. On average, 3.5, 4.2, and 6.4 shoots induced per explant were obtained for genotypes B, C, and D, respectively. Several doses (0.1, 0.3, and 0.5%) of ethyl methane sulfonate (EMS) and different exposure times (1, 2, and 3 h) were applied to investigate the effect of the chemical mutagen on the formation of axillary buds. Genetic variation among the collected plants, the micro-propagated plants during three sub-cultivations, and the plants regenerated in the presence of the mutagen was evaluated by means of randomly amplified microsatellite polymorphism (RAMP) markers. A high genetic stability was observed in the micro-propagation of Mexican oregano for the three genotypes and three sub-cultivations, presenting 100% of monomorphic bands. The genetic variation observed in the different collections of wild populations (A, R, and V) and after treatment with EMS regarded 34 and 35% of polymorphic loci, respectively

Influencia del medio de cultivo sobre la cinética de crecimiento y expresión de la proteína recombinante Rv2626c de Mycobacterium tuberculosis H37Rv expresada en Streptomyces lividans TK24

Streptomyces lividans, ha ganado gran atención en los últimos tiempos, como vector de expresión y producción de proteínas de Mycobacterium tuberculosis de interés biomédico, como alternativa a su obtención tradicional en E. coli. La proteína Rv2626c, Proteína de Respuesta Hipóxica 1, es codificada por el gen Rv2626c (hrp1) de M. tuberculosis, perteneciente al regulón de la fase de latencia DosR. Esta proteína se sobre-expresa en la fase de latencia de la tuberculosis bajo condiciones de estrés como hipoxia y bajos niveles, de óxido nítrico. Se ha demostrado la inmunogenicidad y capacidad de esta proteína, de inducir citocinas características del patrón Th-1, tales como el interferón gamma. Por ello, nuestro grupo logró la obtención de Rv2626c por la tecnología del ADN recombinante usando como cepa hospedera Streptomyces lividans TK24. Con el objetivo de aumentar el nivel de expresión de la proteína recombinante, rRv2626c en este trabajo se ensayaron diferentes medios de cultivo, evaluando el crecimiento de la cepa transformada en condiciones de zaranda. Se determinó la cinética de crecimiento en el medio definido, formulado industrialmente en el Centro Nacional de Biopreparados: caldo Triptona Soya (TSB-BioCen) y en medio de cultivo equivalente preparado en el laboratorio. Para establecer la cinética de crecimiento, se utilizó el cálculo del peso seco y la determinación de la concentración de proteínas totales por la técnica de ácido bicinconinico (BCA) a diferentes tiempos del cultivo. Posteriormente, se identificó la proteína clonada mediante SDS-PAGE y Western Blotting, así como los niveles de expresión mediante análisis densitométrico. Los resultados indican que se alcanzaron los máximos niveles de densidad celular a las 36 h de cultivo y los más altos niveles de expresión proteica total y específica entre las 42 y 54 h. Con el medio químicamente definido TSB-Biocen preformulado en lugar del preparado en el laboratorio partiendo de los componentes, se logró reducir el tiempo óptimo para la expresión-secreción de la proteína rv2626c de 96 a 54 h. Los mejores resultados en la promoción de la expresión de la proteína recombinante se lograron con el medio definido TSB-BioCen, a las 48 h con 8,5% de rendimiento específico, superando en más de 10 veces los niveles de crecimiento celular obtenidos con el medio elaborado en el laboratorio y más de dos veces los niveles de secreción de la proteína recombinante

Surveillance Web System and Mouthwash-Saliva qPCR for Labor Ambulatory SARS-CoV-2 Detection and Prevention

This study provides a safe and low-cost in-house protocol for RT-qPCR-based detection of SARS-CoV-2 using mouthwash&ndash;saliva self-collected specimens to achieve clinical and epidemiological surveillance in a real-time web environment applied to ambulatory populations. The in-house protocol comprises a mouthwash&ndash;saliva self-collected specimen, heat virus inactivation, and primers to target virus N-gene region and the human RPP30-gene. Aligning with 209 SARS-CoV-2 sequences confirmed specificity including the Alpha variant from the UK. Development, validation, and statistical comparison with official nasopharyngeal swabbing RT-qPCR test were conducted with 115 specimens of ambulatory volunteers. A web&ndash;mobile application platform was developed to integrate a real-time epidemiological and clinical core baseline database with mouthwash&ndash;saliva RT-qPCR testing. Nine built-in algorithms were generated for decision-making on testing, confining, monitoring, and self-reports to family, social, and work environments. Epidemiological and clinical follow-up and SARS-CoV-2 testing generated a database of 37,351 entries allowing individual decision-making for prevention. Mouthwash&ndash;saliva had higher sensitivity than nasopharyngeal swabbing in detecting asymptomatic and mild symptomatic cases with 720 viral copy number (VCN)/mL as the detection limit (Ct = 37.6). Cycling threshold and viral loading were marginally different (p = 0.057) between asymptomatic (35 Ct &plusmn; 2.8; 21,767.7 VCN/mL, range 720&ndash;77,278) and symptomatic (31.3 Ct &plusmn; 4.5; 747,294.3 VCN/mL, range 1433.6&ndash;3.08 &times; 106). We provided proof-of-concept evidence of effective surveillance to target asymptomatic and moderate symptomatic ambulatory individuals based on integrating a bio-safety level II laboratory, self-collected, low-risk, low-cost detection protocol, and a real-time digital monitoring system. Mouthwash&ndash;saliva was effective for SARS-CoV-2 sampling for the first time at the community level